Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Elamipretide in Barth Syndrome
NCT07531251Phase 4Recruiting
- Sponsor
- Stealth BioTherapeutics
- Start
- Jul 2026
- Primary completion
- Sep 2029
- Modality
- Peptides, Small Molecules
- Countries
- 3
01
Overview
A Phase 4 trial of elamipretide in Barth syndrome (BTHS), sponsored by Stealth BioTherapeutics. Started Jul 2026; status: recruiting.
02
Drugs
elamipretide
03
Conditions
Barth syndrome (BTHS)
Beyond the preview
Go deeper on NCT07531251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07531251.